Search results for "Enteropathy"

Olmesartan may be associated with higher rate of enteropathy versus other ARBs

The association appeared to be stronger among patients ages 65 years and older, those who were treated for more than a year, and those with higher cumulative olmesartan doses.
https://gastroenterology.acponline.org/archives/2018/02/23/3.htm
23 Feb 2018